AbbVie

Strong growth across the portfolio at AbbVie, a life sciences firm with operations in Worcester, drove profits up 4.3 percent in the first quarter, the company reported Thursday.

Pharmaceutical giant AbbVie, which has operations in Worcester, will acquire Pharmacyclics, maker of the blood cancer treatment Imbruvica (ibrutinib).

Life sciences firm AbbVie, which has operations in Worcester, saw a nearly 9-percent increase in fourth-quarter revenue, helped by double-digit growth in its popular arthritis drug, Humira.

Pharmaceutical giant AbbVie, which has operations in Worcester, has boosted its earnings estimates for 2015 by 30 percent amid rising sales for its arthritis drug Humira and the launch of its treatment for hepatitis C, the company announced late last week.

Less than two weeks after abandoning a $55 billion deal to buy rival Shire following changes to U.S. tax rules, Illinois-based drug maker AbbVie raised its annual earnings guidance after sales of its top drug grew 17 percent.

AbbVie, a Chicago-based company with a research and development facility in Worcester, announced Thursday that results from...

Global sales for Illinois-based drug firm AbbVie rose 5 percent in the second quarter, driven primarily by a 26-percent jump in sales for its arthritis drug Humira.

In what has been termed the biggest corporate takeover of 2014 to date, Illinois-drug maker AbbVie, which employs about 700 in Worcester at a research and development facility, has agreed to buy Dublin-based Shire in a $54 billion deal announced Friday morning.

Illinois-based AbbVie reported that worldwide net sales rose 5.4 percent, to $4.6 billion in the first quarter of 2014, over 2013. The pharmaceutical firm also reported net earnings of $980 million or 61 cents per share.

AbbVie has announced plans to build a $320 million manufacturing plant in Singapore, its first in Asia.